795551--3/8/2007--THERAGENICS

related topics

{product, market, service}

{acquisition, growth, future}

{product, liability, claim}

{cost, regulation, environmental}

{property, intellectual, protect}

{regulation, change, law}

{personnel, key, retain}

{stock, price, operating}

{regulation, government, change}

{loan, real, estate}

{financial, litigation, operation}

{customer, product, revenue}

Risks Related to our Business There are risks associated with our acquisitions, potential acquisitions and joint ventures. We may not realize the benefits of acquisitions. The cost of acquisitions could harm our financial results. We are dependent on key personnel. Our stock price has been and may continue to be subject to large fluctuations. We are subject to stringent government regulation. We face risk related to lack of diversification. We are dependent on new technological development. We are highly dependent on our marketing and advertising specialists and our direct sales organization in the brachytherapy business. Any failure to build and manage our direct sales organization could negatively affect our revenues. We depend partially on our relationships with distributors and other industry participants to market our brachytherapy and surgical product s, and if these relationships are discontinued or if we are unable to develop new relationships, our revenues could decline. Doctors and hospitals may not adopt our products and technologies at levels sufficient to sustain our business or to achieve our desired growth rate. Evolving regulation of corporate governance and public disclosure may result in additional expenses and continuing uncertainty. There are limitations on our ability to protect our intellectual property and we are dependent on trade secrets. We are dependent on Medicare reimbursement policies and policies of other third party payors. We may be unable to maintain sufficient liability insurance. If we do not comply with laws and regulations relating to our use of hazardous materials, we may incur substantial liabilities. Litigation may harm our business or otherwise distract our management. Defects in, or misuse of, our products, or any detrimental side effects that result from the use of our products, could result in serious injury or death and could require costly recalls or subject us to costly and time-consuming product liability claims. This could harm future sales and require us to pay substantial damages. We may require additional capital in the future and we may be unable to obtain capital on favorable terms or at all. If we are unable to develop new enhancements and new generations, we may be unable to retain our existing customers or attract new customers.

Full 10-K form ▸

795551--3/8/2007--THERAGENICS_CORP